 |
HIV Vaccines Studies
Immune based therapy, or treatment that works by helping the body's immune responses (the ability to fight infection), has been studied to see if it is promising as a treatment for HIV and if it is safe and well tolerated in people infected with HIV. Anti-HIV vaccines are being examined to see if they are safe in people infected with HIV. Additionally, studies are looking at whether or not the anti-HIV vaccines can improve the body's ability to fight infection.
The UCLA CARE Center has a study open that examines novel vaccine therapies for HIV:
DNA Vaccine (ACTG 5281)
Study for HIV+ men and women taking HIV medications to further test the safety of a DNA vaccine and see if it improves the body's ability to fight infection (immune response). The vaccine will be administered using an experimental hand-held device that injects the vaccine along with an electrical signal to deliver the vaccine into the upper arm muscle. This procedure may enhance the effect of this vaccine.
For Spanish language study flyer, click here »
For more information about the UCLA CARE Center's clinical trials and research studies, please contact:
Phone: (310) 557-9062
Email: CAREOutreach@mednet.ucla.edu
